Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$3.83 USD
-0.11 (-2.79%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.82 -0.01 (-0.26%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.91 | 6.64% |
Earnings Summary
For their last quarter, Sutro Biopharma (STRO) reported earnings of $0.42 per share, beating the Zacks Consensus Estimate of $-0.82 per share. This reflects a positive earnings surprise of 151.22%. Look out for STRO's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.91 per share, reflecting a year-over-year decrease of 19.74%.
Earnings History
Price & Consensus
Zacks News for STRO
Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
STRO: What are Zacks experts saying now?
Zacks Private Portfolio Services